Allogeneic bone marrow supports human islet beta cell survival and function over six months

Area of Science:

• * Regenerative Medicine
• * Endocrinology
• * Cell Biology

Background:

• * Human islet transplantation is a potential therapy for type 1 diabetes.
• * Current limitations include poor long-term islet survival and function.
• * Novel strategies are needed to improve islet engraftment and viability.

Purpose of the Study:

• * To investigate the potential of allogeneic whole bone marrow (BM) co-culture to enhance human islet longevity.
• * To evaluate the functional and survival benefits of this co-culture system.
• * To determine if BM co-culture can restore or improve beta cell function.

Main Methods:

• * Human islets were co-cultured with allogeneic whole bone marrow (BM).
• * Islet survival and function were assessed via insulin secretion assays in response to glucose challenge.
• * Morphological evaluation of cell growth and tissue formation was performed.

Main Results:

• * Human islets cultured alone demonstrated limited long-term survival, growth, and function.
• * Co-culture with BM significantly improved human islet survival and function.
• * Evidence of new pancreatic endocrine tissue formation was observed in BM co-cultures.

Conclusions:

• * Allogeneic whole bone marrow (BM) co-culture is a promising strategy for increasing human islet longevity.
• * This approach supports sustained beta cell function and promotes the development of functional pancreatic endocrine tissue.
• * BM co-culture represents a novel method to improve outcomes for islet transplantation therapies.